Delivery Order SPE2DX22D0010-SPE2D826FBV83
Award Date 12/18/25
Potential Completion Date 12/19/25
Potential Value $6.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26 and an ultimate completion date of August 25, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg, valued at $11,133.62. This firm fixed-price delivery order, with an ultimate completion date of November 4, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's continued capability...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg, a controlled-release pain management pharmaceutical. This non-set-aside, competitively awarded delivery order has a ceiling value of $15,791.14 and a firm fixed-price structure, with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Oxymorphone HCL ER 20 mg tablets in quantities of 60 units, with a contract ceiling value of $1,216.15. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order on October 22, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Oxymorphone HCL ER Tablets 20mg with a ceiling value of $5,773.98. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,990.02 on August 6, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg to the Defense Logistics Agency's Medical Supply Chain. The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,198.34 to AmerisourceBergen Drug Corp for Oxymorphone HCL ER 20 mg tablets (60-count supply). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 2, 2025. The award was issued on August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Oxymorphone HCL ER Tablets 20mg, valued at $11,664.15 under a firm fixed-price contract type. This non-competitive delivery order represents a single-item pharmaceutical procurement with an ultimate completion date of August 21, 2025. The award was made without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,981.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxymorphone HCL ER 20 mg tablets (60-count) on September 19, 2025, with completion targeted for September 22, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The award is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,276.50 firm fixed price delivery order is for the supply of Oxymorphone HCL ER Tablets 15mg, a pain management medication. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...